However, the fact that irisin improves glucose homeostasis and insulin resistance clearly indicates the therapeutic potential of irisin for insulin resistance in patients with CKD.[13] The efficacy of irisin in improving the outcome of CKD patients with cardiovascular disease is of worth investigating. This evidence concerns the gene FNDC5 and Insulin resistance.